That study showed a net increase only of 27-OH in the frontal cortex of AD brains compared to age-matched normal ones, while 24-OH levels in AD frontal cortex specimens were reported to be unchanged (Heverin et al., 2004).
It is reported that GVD occurs in adult control brains and increases slightly with increasing age, however, the occurrence of GVD in AD brain is increased compared to age-matched control brain [ 4, 122].
In addition, examination of γH2AX foci in both newborn and 12-month old mouse brains demonstrates that, as with MEFs, significantly more γH2AX foci are seen in the brains of Nfkb1 −/− compared to age-matched Nfkb1 +/+ animals (p<0.01, Fig. 4D).
Analysis of PSP brains via Western blot and ELISA revealed the presence of increased levels of tau oligomers compared to age-matched control brains.
CD11b staining was dramatically increased in the brain of MPSIIIB mice at 3 months, compared to age-matched wild type mice (figure 4A).
Postmortem analysis of multiple brain regions in advanced PD with dementia compared to age-matched neurologically normal controls revealed widespread reductions in neurotransmitter levels of DA, 5HT, and NE, along with reductions in their corresponding transporter proteins, DAT and SERT.
This led to a significant reduction in brain and body weight gain in hypoxic pups compared to age-matched normoxia-reared controls, plausibly reflecting an inability to fulfill the energetic needs of normal growth and development.
Late phase-LTP (L-LTP) was significantly enhanced in aged Tg mice compared to age-matched WT mice.
In brains of FTLD patients several CpG units in the GRN promoter are significantly hypermethylated compared to age-matched healthy controls, Alzheimer and Parkinson patients.
In postmortem brain DNA analyses of AD patients, the DNA methylation status of telomerase reverse transcriptase (HTERT) was elevated compared to age-matched healthy individuals, however hypermethylation of HTERT was not accompanied by reduced mRNA expression in this study [ 38].
